Differential Diagnoses
1. Upper Gastrointestinal Bleeding Secondary to NSAID-Induced Peptic Ulcer Disease
This is the most likely diagnosis given the melena, syncope, anemia (pale conjunctivae), and high-risk medication profile. 1
The patient is taking etoricoxib (Arcoxia), a COX-2 selective inhibitor, without gastroprotection despite being 67 years old—a critical oversight. 1 According to evidence-based guidelines, patients ≥65 years on COX-2 inhibitors should receive a proton pump inhibitor (PPI) for gastroprotection, yet this patient received none. 1 The combination of:
- Age ≥65 years (4-point increase in GI risk) 1
- COX-2 inhibitor use without PPI (inappropriate prescribing per guidelines) 1
- Black, tarry stool (melena) indicating upper GI source
- Progressive weakness and pale conjunctivae suggesting anemia from blood loss
- Epigastric pain worsening after meals (classic ulcer pattern)
- Syncope and presyncope from hypovolemia/anemia
The etoricoxib significantly increases GI ulcer risk—studies show 8.1% cumulative incidence of ulcers at 12 weeks even at 120mg daily, though lower than traditional NSAIDs. 2 However, without PPI protection in a geriatric patient, this risk becomes clinically significant. 1 The melena three days prior represents the sentinel bleed, with ongoing occult bleeding causing progressive anemia leading to syncope. 3
Critical pitfall: COX-2 inhibitors are often mistakenly considered "safe" for the GI tract—they reduce but do not eliminate ulcer risk, especially in elderly patients without PPI co-therapy. 1, 2
2. Orthostatic Hypotension from Polypharmacy and Hypovolemia
The combination of antihypertensive medications (losartan and amlodipine) with acute blood loss creates a perfect storm for orthostatic syncope. 3
The patient exhibits classic features of orthostatic intolerance: 3
- Recurrent lightheadedness upon standing (attempting to board tricycle)
- Transient presyncope with "blanking out" (near-syncope episode) 3
- Frank syncope while upright (unwitnessed collapse)
- Progressive weakness suggesting volume depletion
Her blood pressure of 140/90 mmHg on day 9 of admission (after resuscitation) suggests she may have been significantly hypotensive at presentation. 4 Losartan can cause syncope as a documented adverse effect (listed in FDA labeling), particularly in volume-depleted states. 4 The combination with amlodipine compounds this risk.
The syncope definition from ACC/AHA/HRS guidelines fits perfectly: "abrupt, transient, complete loss of consciousness with inability to maintain postural tone, with rapid and spontaneous recovery" due to cerebral hypoperfusion. 3 The unwitnessed nature and spontaneous recovery are typical. 3
Key consideration: Delayed orthostatic hypotension (>3 minutes to develop) is common in elderly patients and may not be detected on routine vital sign checks. 3
3. Medication-Induced Constipation with Fecal Impaction and Vasovagal Syncope
Amlodipine is a well-documented cause of constipation, with 4-fold increased relative risk compared to combination therapy. 5
The clinical picture includes: 5, 6
- Progressive constipation (patient's chief complaint component)
- Abdominal distention (noted on physical exam)
- Hyperactive bowel sounds (suggesting obstruction or impaction)
- Epigastric pain (from distention)
- Straining-induced vasovagal syncope (common with severe constipation)
Amlodipine dose-dependently inhibits intestinal motility, and this patient has been on it chronically for hypertension. 5, 6 The black stool could represent impacted stool rather than melena—though the "wet" consistency argues against this. The combination of colchicine (which can cause diarrhea or constipation) and amlodipine creates competing GI effects. 5
Fecal impaction can cause: 5
- Overflow diarrhea (paradoxical)
- Vasovagal episodes from straining
- Abdominal pain
- Systemic symptoms from toxin absorption
Pitfall to avoid: Always differentiate true melena (sticky, tar-like, foul-smelling) from dark stool due to iron, bismuth, or impaction. The patient could not recall the odor, which is suspicious. 5
4. Cardiac Syncope from Arrhythmia or Structural Heart Disease
Given her age, hypertension, and multiple cardiovascular risk factors, cardiac causes must be excluded. 3
Red flags for cardiac syncope include: 3
- Age 67 with longstanding hypertension (left ventricular hypertrophy risk)
- Syncope without prodrome (unwitnessed, sudden collapse suggests arrhythmic cause) 3
- Recurrent episodes (presyncope then syncope)
- Exertional component (attempting to board vehicle)
- Medications affecting cardiac conduction (losartan, amlodipine)
The ACC/AHA/HRS guidelines emphasize that cardiac syncope carries higher mortality risk and requires urgent evaluation. 3 Potential mechanisms include:
- Bradyarrhythmia (amlodipine can rarely cause bradycardia; losartan lists palpitations and atrial fibrillation as adverse effects) 4
- Ventricular tachycardia (from LVH in chronic hypertension)
- Aortic stenosis (exertional syncope pattern)
- Acute coronary syndrome (epigastric pain can be anginal equivalent)
The FDA labeling for losartan specifically lists syncope, atrial fibrillation, and CVA as reported adverse cardiac events. 4 Her blood pressure of 140/90 suggests inadequate hypertension control, increasing LVH risk.
Critical action: ECG, telemetry monitoring, and echocardiography are mandatory to exclude life-threatening cardiac causes before attributing syncope to other etiologies. 3